Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-018702
Filing Date
2025-05-13
Accepted
2025-05-13 17:23:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 ny20048472x1_424b5.htm 424B5 630143
2 logo_sangamo-tm.jpg GRAPHIC 42770
3 logo_sangamo.jpg GRAPHIC 33952
4 logo_sangamox2.jpg GRAPHIC 54432
  Complete submission text file 0001140361-25-018702.txt   811387
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283179 | Film No.: 25941465
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)